Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine
Yan Li(Third Affiliated Hospital of Southern Medical University), Jinfeng Zhang(Insilicos (United States)), Qiang Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Feng Mao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yidong Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Max M. He, Tingting Zhao(Florida State University), Philip C. Miller(University of Miami), Albert Steppi(Florida State University)
Cited by 57
Related Papers
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
|Nature Medicine|2018|1.2k
Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease Risk
|Journal of the American College of Cardiology|2010|913
Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types
|Genome Research|2010|647
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
|Clinical Cancer Research|2011|338
Reactivity of Thioredoxin as a Protein Thiol-Disulfide Oxidoreductase
|Chemical Reviews|2011|140